ASP Isotopes Inc.

Analysis for Ticker: ASPI

ASP Isotopes Inc operates as a development stage materials company that claims to enrich isotopes for nuclear medicine, semiconductors, and green energy fuels at a facility in Pretoria South Africa. The business tells a story of high technology, but the math reveals a company that produces zero commercial isotopes while extracting 320,3$ million from the public in one year. It is like a company that promises to build a rocket but spends all its time selling pieces of the rocket to neighbors to pay for the pilots' expensive suits. With an accumulated deficit of 231,2$ million and a net loss of 159,8$ million in 2025, the enterprise is incinerating cash while the people running it take millions in free shares. The current math is a disaster because the company burns through cash much faster than it can ever hope to earn it, requiring a constant stream of new investors to pay for the previous ones.